scholarly journals Evaluation of Hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model

Author(s):  
Ben G.L. Vanneste ◽  
Ludy Lutgens ◽  
Evert J. Van Limbergen
2016 ◽  
Vol 5 (12) ◽  
pp. 112 ◽  
Author(s):  
Masako Fujioka-Kobayashi ◽  
Benoit Schaller ◽  
Eizaburo Kobayashi ◽  
Maria Hernandez ◽  
Yufeng Zhang ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 9 (3) ◽  
pp. 3338-3352 ◽  
Author(s):  
Chenrui Li ◽  
Zhijun Wang ◽  
Qian Wang ◽  
Rebecca Lucinda Ka Yan Ho ◽  
Ying Huang ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 7 (40) ◽  
pp. 65418-65428 ◽  
Author(s):  
Ting Lan ◽  
Ji Pang ◽  
Yan Wu ◽  
Miaolin Zhu ◽  
Xiaoyuan Yao ◽  
...  

2019 ◽  
Vol 29 (1) ◽  
pp. 129-140
Author(s):  
Kun Wang ◽  
Xiao long Li ◽  
Jinbo Liu ◽  
Xiaoliang Sun ◽  
Huilin Yang ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
S. Inder ◽  
M. Bates ◽  
N. Ni Labhrai ◽  
N. McDermott ◽  
J. Schneider ◽  
...  

AbstractThe exact biological mechanism governing the radioresistant phenotype of prostate tumours at a high risk of recurrence despite the delivery of advanced radiotherapy protocols remains unclear. This study analysed the protein expression profiles of a previously generated isogenic 22Rv1 prostate cancer model of radioresistance using DigiWest multiplex protein profiling for a selection of 90 signalling proteins. Comparative analysis of the profiles identified a substantial change in the expression of 43 proteins. Differential PARP-1, AR, p53, Notch-3 and YB-1 protein levels were independently validated using Western Blotting. Pharmacological targeting of these proteins was associated with a mild but significant radiosensitisation effect at 4Gy. This study supports the clinical relevance of isogenic in vitro models of radioresistance and clarifies the molecular radiation response of prostate cancer cells.


Medicina ◽  
2021 ◽  
Vol 57 (3) ◽  
pp. 285
Author(s):  
Elena Canciani ◽  
Riccardo Sirello ◽  
Gaia Pellegrini ◽  
Dolaji Henin ◽  
Mariachiara Perrotta ◽  
...  

Background and Objectives: Wound healing is a dynamic process that can be compromised in patients with chronic and metabolic conditions or unhealthy lifestyles. Numerous medical substances designed for topical use, charged with compounds that promote the healing process, have been developed to improve wound healing, especially in compromised subjects. The present study aimed to extend our understanding of the in vivo effects of a hyaluronic acid gel charged with amino acids (HAplus gel, Aminogam gel® Errekappa Euroterapici spa, Milan, Italy) and study the in vitro effects of the same gel charged with additional substances in an attempt to optimize its formulation. Materials and Methods: In a randomized controlled split-mouth clinical and histological trial, HAplus gel was tested on the gingival tissue of the lower third molar post-extraction socket. The gingiva was collected at the time of extraction (T0) and ten days after the extraction (T1) to be histologically analyzed. During the second stage of the study, culture media with HAplus gel and vitamin C and E at different concentrations (TEST) were tested on human gingival fibroblasts and compared to the HAplus-enriched medium (HA-Control). Results: Histological and immunohistochemical analysis of collected gingiva showed higher microvascular density and collagen fibers organized in closely packed and well-oriented bundles in sites treated with HAplus gel. In the in vitro study, all TEST groups showed an increased viability from 24 h to 48 h. After 24 h, the viability percentage in all experimental groups was below 100% of the HA-Control, demonstrating a mild toxicity. After 48 h from seeding, the TEST groups’ viability grew significantly compared to HA-Control. Conclusions: These encouraging preliminary results suggest that the use of HAplus gel enriched with vitamins C and E may be beneficial in patients with conditions that impair soft tissue healing.


2014 ◽  
Vol 110 (2) ◽  
pp. 348-354 ◽  
Author(s):  
Shuraila F. Zerp ◽  
Conchita Vens ◽  
Ben Floot ◽  
Marcel Verheij ◽  
Baukelien van Triest

2021 ◽  
Author(s):  
Donghui Pan ◽  
Lizhen Wang ◽  
Xinyu Wang ◽  
Junjie Yan ◽  
YuPing Xu ◽  
...  

Abstract Purpose: Radiolabeled FSH1 peptides are potential specific probes for FSHR imaging. However, moderate uptakes and fast washout from the tumors may limit its widespread use. In this study, 68Ga labeled modified FSH1 analogs was prepared and the imaging properties were determined in the prostate cancer model with or without aprotinin.Methods: NOTA-MAL-FSH4 was synthesized and labeled with 68Ga. The pharmacokinetic profile of the peptide after co-administration with aprotinin was determined through metabolism analyses and microPET imaging.Results: 68Ga-NOTA-MAL-FSH4 was successfully prepared. The IC50 value of displacement 68Ga-NOTA-MAL-FSH4 with FSH1 was 139.4±1.16 nM. The PC-3 prostate tumor was visible after administration of the 68Ga labeled tracer. In vitro RP-HPLC analysis revealed that the average percentage of intact peptide in the plasma, liver and tumor was 8.30, 9.57 and 7.06 % respectively. In presence of aprotinin, the amounts of intact peptide increased to 34.32%, 20.63 % and 15.39 % in the counterparts respectively. MicroPET imaging showed that the uptakes of PC-3 tumors at 60mins after co-administration of 100μg, 200μg or 400μg enzyme inhibitors were 2.91±0.21%ID/g, 3.89±0.16%ID/g and 9.21±0.22%ID/g respectively.Conclusion: With the aid of a serine protease inhibitor, the performance of the 68Ga labeled peptide was optimized, which may benefit further clinical application.


Sign in / Sign up

Export Citation Format

Share Document